Display options
Cite
Chen YF, Wang YW, Chen IS, et al. Cyclohexylamine, an active compound from . Biomedicine (Taipei). 2020;10(2):12-22doi: 10.37796/2211-8039.1025.
Chen, Y. F., Wang, Y. W., Chen, I. S., & Tsai, H. Y. (2020). Cyclohexylamine, an active compound from . BioMedicine, 10(2), 12-22. https://doi.org/10.37796/2211-8039.1025
Chen, Yuh-Fung, et al. "Cyclohexylamine, an active compound from ." BioMedicine vol. 10,2 (2020): 12-22. doi: https://doi.org/10.37796/2211-8039.1025
Chen YF, Wang YW, Chen IS, Tsai HY. Cyclohexylamine, an active compound from . Biomedicine (Taipei). 2020 Jun 05;10(2):12-22. doi: 10.37796/2211-8039.1025. eCollection 2020. PMID: 33854916; PMCID: PMC7608847.
Copy Download .nbib Format: NLM
Share it on

Biomedicine (Taipei). 2020 Jun 05;10(2):12-22. doi: 10.37796/2211-8039.1025. eCollection 2020.

Cyclohexylamine, an active compound from .

BioMedicine

Yuh-Fung Chen, Yu-Wen Wang, Ih-Sheng Chen, Huei-Yann Tsai

Affiliations

  1. Department of Pharmacology, China Medical University, Taichung, Taiwan.
  2. School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.
  3. Department of Pharmacy, China Medical University Hospital, Taichung, Taiwan.

PMID: 33854916 PMCID: PMC7608847 DOI: 10.37796/2211-8039.1025

Abstract

METHODS: Male S.D. rats weighting between 200 g to 250 g were used. The epididymal portion of vas deferens was isolated and was added with various concentrations of serotonin, serotonin antagonists and CHA.

RESULTS: Serotonin elicited dose-dependent (1 × 10

CONCLUSIONS: From the above results, the contraction evoked by CHA on the isolated rat epididymal vas deferens might be mediated by serotonergic receptors through 5-HT

© the Author(s).

Keywords: Cyclohexylamine; Isolated rat epididymal vas deferens; Serotonergic receptors; Serotonin 5-HT2A subtype; primary

Conflict of interest statement

The authors wish to declare no conflicts of interest on this work.

References

  1. Br J Pharmacol. 1975 Aug;54(4):481-8 - PubMed
  2. Arch Int Pharmacodyn Ther. 1984 Jun;269(2):236-51 - PubMed
  3. BMC Complement Altern Med. 2018 Sep 26;18(1):261 - PubMed
  4. Ethiop J Health Sci. 2016 Jan;26(1):55-64 - PubMed
  5. Phytochemistry. 1998 Aug;48(8):1377-82 - PubMed
  6. Pan Afr Med J. 2013 Apr 06;14:133 - PubMed
  7. Biochem Biophys Res Commun. 2014 Oct 31;453(4):787-92 - PubMed
  8. Crit Rev Toxicol. 1986;16(3):213-306 - PubMed
  9. Arch Int Pharmacodyn Ther. 1990 Nov-Dec;308:76-85 - PubMed
  10. J Pharm Pharmacol. 1986 Oct;38(10):737-41 - PubMed
  11. Biochem J. 1972 Oct;129(4):881-90 - PubMed
  12. Exp Mol Pathol. 1990 Apr;52(2):155-69 - PubMed
  13. Br J Pharmacol. 1982 Dec;77(4):605-13 - PubMed
  14. Life Sci. 1969 Aug 1;8(15):843-53 - PubMed
  15. Xenobiotica. 1974 Jul;4(7):425-39 - PubMed
  16. Toxicology. 1977 Oct;8(2):143-56 - PubMed
  17. Chem Pharm Bull (Tokyo). 1966 Sep;14(9):971-4 - PubMed
  18. Science. 1970 Feb 20;167(3921):1131-2 - PubMed
  19. Biull Eksp Biol Med. 1977 Feb;83(2):173-5 - PubMed
  20. Jpn J Pharmacol. 1985 Mar;37(3):285-91 - PubMed
  21. Trends Pharmacol Sci. 1998 Feb;19(2):46-8 - PubMed
  22. J Pharmacol Exp Ther. 1969 Nov;170(1):62-71 - PubMed
  23. Food Cosmet Toxicol. 1981 Jun;19(3):291-6 - PubMed
  24. Indian J Pharm Sci. 2015 Nov-Dec;77(6):788-91 - PubMed
  25. Diabetes Care. 1989 Jan;12(1):50-5; discussion 81-2 - PubMed
  26. Naunyn Schmiedebergs Arch Pharmacol. 1990 Aug;342(2):130-5 - PubMed
  27. J Pharmacol Exp Ther. 1985 Mar;232(3):770-4 - PubMed
  28. Eur J Pharmacol. 1986 Dec 2;132(1):39-46 - PubMed
  29. Phytomedicine. 2012 Jun 15;19(8-9):737-46 - PubMed
  30. Br J Pharmacol. 1976 Oct;58(2):276P-277P - PubMed
  31. J Ethnopharmacol. 2013 Jan 30;145(2):587-90 - PubMed
  32. Food Chem. 2014 Apr 1;148:437-44 - PubMed
  33. J Pharmacol Exp Ther. 1981 Jul;218(1):217-30 - PubMed
  34. Neuroscience. 1976 Jun;1(3):197-203 - PubMed
  35. J Pharmacol Exp Ther. 1990 Sep;254(3):1012-6 - PubMed

Publication Types